Skip links

Digital Business: An Unlimited Opportunity

Jump To Section

In today’s business world there is an unlimited opportunity to grow revenue, profit, cash, and market share.
Digital Business: An Unlimited Opportunity

Unveiling Digital Business Opportunities

In today’s business world there is an unlimited opportunity to grow revenue, profit, cash, and market share. Digital business growth can enable all of these outcomes, however, for many companies achieving them is impeded by difficulty in pivoting from the current complex business and technology operations environment towards a true agile digital business model.

There are three areas of fundamental aspects to leverage in transitioning from a traditional focus on business and technology to a digital business construct.

1. Simplification is the process to reevaluate the current business and technology with the intent to make the existing operations efficient and inherently flexible. This is the foundation to enable the enterprise to more easily create new digital products and businesses for growth.

2. Focus on small steps to create an environment where the business and technology are committed and aligned on an approach to address specific business needs. Avoid a big bang mindset, rather emphasize collaboration for an end-to-end approach to achieve business outcomes.

3. A simple business digital platform (BDP) to help businesses and technology in their collaboration and iteration of data from various sources for effective decision making and predictive analysis, with speed and without disrupting current business operations.

Digital Business Growth

CEOs Driving Unified Business-Tech Collaboration for Growth & Innovation

The CEO and senior leaders play a pivotal role in communicating and instilling a culture of collaboration across the organization. Prioritization for every initiative must be tied to business growth driven by simplification and dedicated teams to implement solutions. The digital business roadmap should be designed so that initiatives will not disrupt current business operations or the end customer. It is also crucial to create a single source of truth across every business function of the organization, enabling better planning and pro-activeness, deeper business intelligence, and creating new business models based on insights gleaned from customer needs.

Large enterprises are struggling with the issues arising out of a lack of collaboration between business and technology which can impact the current business. Many of them are struggling, not having a productive engineering environment where business and technology can collaborate with a product approach (assets). They need a simple BDP in the cloud which can leverage the current technology assets, including platforms, to bring consistent engineering of products across the enterprise at scale. Other benefits of an agile end-to-end engineering environment are speed, reusability of assets, faster product launches, security, and compliance.

Also read: Why Digital Businesses drive growth and profitability

Mid-size companies are challenged with where to start and how to address several pain points affecting the current business as well as not having clear visibility into day-to-day challenges. They also have a perception that digital business implementation is very expensive, lengthy, and disruptive to the current business. They need to take the following steps to bring outcomes at speed, without requiring a large investment or disrupting current business.

1. Focus on the current business pain points and solve them by simplifying and collaborating through engineering teams. This can be achieved with a strategic business partner who is a catalyst to bring practitioners and engineering teams together with a simple BDP in the cloud

2. Place an emphasis on digitalization and creating a single source of truth across each individual business function and eventually across all business functions. This will help to bring teams with the right culture of collaboration and problem solving together without the worry of attracting additional talent. It also avoids a high upfront investment in technology. The key focus is to solve current pain points and create new opportunities for growth with speed.

End-to-End Practitioners: Key to Digital Business Success

Another key element of digital business is the use of practitioners who take an end-to-end perspective and understand both the business and technology components. They are adept at simplifying processes across business and technology empowering agile engineering teams to achieve business outcomes. Companies underestimate the importance and success driven by collaboration by an end-to-end approach to creating new products at speed. It is no longer just a technology issue, it is all about the adherence to simplification, collaboration, and consistency.

At Altimetrik, we are helping many large enterprises and mid-size companies with this approach of practitioners, engineering teams, and a BDP. Practitioners help to simplify while business and technology teams collaborate to efficiently create digital products from ideation to launch. BDP is very flexible and creates an environment to institutionalize product development at scale with speed. This is a specific business outcome-focused process that avoids the big bang approach, and it accelerates digital business growth in a consistent manner.

Picture of Raj Vattikuti

Raj Vattikuti

Raj Vattikuti is an American-Indian entrepreneur, business executive and philanthropist. He is the Founder and Chairman of Altimetrik Corp. He is also the founder of Vattikuti Foundation. through which he is involved in many charitable causes.

Latest Reads


Suggested Reading

Ready to Unlock Your Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes